Brief: Astrazeneca Pharma India Gets Tax Order With Estimated Tax Impact Of 33 Million Rupees
27/11/2025 14:46
Nov 27 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA LTD - GETS TAX ORDER WITH ESTIMATED TAX IMPACT OF 33 MILLION RUPEES Source text: ID:nNSE9gThnL Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan